de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis.

MPG-Autoren

Ungethuem,  U.
Max Planck Society;

Witt,  H.
Max Planck Society;

Drungowski,  M.
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons50409

Lehrach,  H.
Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

Ruiz,  P.
Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Ungethuem, U., Haeupl, T., Witt, H., Koczan, D., Krenn, V., Huber, H., et al. (2010). Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiological Genomics, 42A(4), 267-282. doi:10.1152/physiolgenomics.00004.2010.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0010-7A4E-3
Zusammenfassung
Rheumatoid arthritis (RA) is a chronic, inflammatory joint disease of unknown etiology and pronounced inter-patient heterogeneity. To characterize RA at the molecular level and to uncover pathomechanisms, we performed genome-wide gene expression analysis. We identified a set of 1054 genes significantly deregulated in pair-wise comparisons between RA and osteoarthritis (OA) patients, RA and normal donors (ND), or OA and ND. Correlation analysis revealed gene sets regulated identically in all three groups. As a prominent example secreted phosphoprotein 1 (SPP1) was identified to be significantly upregulated in RA as compared to both OA and ND. SPP1 expression was found to correlate with genes expressed during an inflammatory response, T cell activation and apoptosis, suggesting common underlying regulatory networks. A sub-classification of RA patients was achieved on the basis of proteoglycan 4 (PRG4) expression distinguishing PRG4 high- and low expressors and reflecting the heterogeneity of the disease. In addition, we found that low PRG4 expression was associated with a more aggressive disease stage, which is in accordance with PRG4 loss-of-function mutations causing camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Altogether we provide evidence for molecular signatures of RA and RA subclasses, sets of new candidate genes as well as for candidate gene networks, which extend our understanding of disease mechanisms and may lead to an improved diagnosis.